A strong distribution network is one of the most important requirements for a pharmaceutical business.

A company may have excellent products, competitive prices, strong medical representatives and good prescriptions, but sales will still suffer if medicines are not available at the required pharmacy, hospital or distributor when customers need them.

For pharmaceutical companies, distribution has an additional responsibility: the medicine must not only reach the customer quickly—it must reach the customer without losing its quality, identity, traceability or required storage conditions.

Therefore, a strong pharmaceutical distribution system should achieve four things:

Right product → Right quantity → Right place → Right condition → Right time

What is a Distribution Channel?

A distribution channel is the commercial and physical route through which a product moves from the manufacturer or marketing company to the final buyer or patient.

A conventional pharmaceutical channel may look like:

Manufacturer / Marketing Company → C&F / Super Stockist → Stockist / Distributor → Retail Pharmacy / Hospital → Patient

However, every company does not need all these levels.

For example, a smaller company may use:

Company → Distributor → Retailer → Patient

A PCD company may use:

Company → PCD Franchise Partner → Retailer / Hospital → Patient

An institutional supplier may use:

Manufacturer → Authorized Distributor → Hospital → Patient

The channel should be designed according to business volume, geography, product characteristics and customer density rather than copying another pharma company.

Distribution Channel vs Supply Chain

These terms are often used as if they mean the same thing, but there is an important difference.

Distribution Channel	Supply Chain
Focuses mainly on getting finished products to customers	Covers the complete flow from suppliers to final customer
Manufacturer to distributor to retailer	Raw material to manufacturing to warehouse to distributor to customer
Mainly downstream	Upstream + internal operations + downstream
Focuses on market coverage	Focuses on procurement, production, inventory and delivery
Includes channel partners	Includes suppliers, manufacturers, transporters, warehouses and customers

For example, purchasing paracetamol API is part of the supply chain, but not normally part of the finished-product distribution channel.

What Is a Delivery Network?

The delivery network is the physical system used to move orders between locations.

It includes matters such as:

• Transporters and couriers
• Local delivery vehicles
• Warehouses
• Regional depots
• Cold-chain vehicles
• Route planning
• Delivery schedules
• Proof of delivery
• Return collection

A company may have many distributors but still have a poor delivery network if products take five days to reach retailers.

Main Participants in a Pharma Distribution Channel

Participant	Main Role
Manufacturer	Produces and releases medicines
Marketing company	Generates business and manages brands/channel
C&F agent	Stores and dispatches stock for a defined territory
Super stockist	Holds larger regional inventory
Stockist	Supplies products within a defined market
Distributor	Distributes to retailers/hospitals; terminology varies by market
Retail pharmacy	Supplies medicines to patients
Hospital pharmacy	Supplies medicines within hospital system
Logistics provider	Physically transports products
Patient/customer	Final user

In Indian trade terminology, “stockist” and “distributor” are sometimes used differently by different companies. Therefore, contracts should define the actual responsibilities rather than relying only on the title.

What Is a C&F Agent?

C&F means Carrying and Forwarding Agent.

A C&F normally does not function exactly like an ordinary distributor. It may hold company inventory and perform activities such as:

• Receiving stock
• Warehousing
• Order processing
• Dispatch
• Documentation
• Inventory reporting
• Return coordination

Whether a company needs a C&F depends on its scale.

A company selling limited quantities in one or two states may not require a separate C&F layer.

A company supplying large volumes across several states may benefit from regional C&F points because they reduce delivery time and central-warehouse pressure.

Is C&F Compulsory?

No.

It is a commercial distribution structure, not a compulsory level that every pharma company must create.

Adding a C&F simply because large companies use one can increase:

• Warehousing cost
• Inventory
• Reconciliation work
• Credit exposure
• Expiry risk

Create an additional distribution level only when the service improvement justifies its cost.

Pharmaceutical Distribution Is a Licensed Activity

Pharmaceutical distribution cannot be structured only around sales convenience.

Sale and distribution of drugs are regulated under the Drugs and Cosmetics framework. Wholesale drug licences commonly involve Forms 20B and 21B depending on the medicines handled and the applicable conditions.

Importantly, CDSCO notified further amendments on 16 February 2026 affecting licence conditions under Forms 20B, 20BB, 21B and 21BB and requirements concerning the competent person.

Therefore, before appointing a distributor, verify that the party has the licences required for the medicines it will stock and sell.

Good Distribution Practices

Medicines can lose quality even after they leave a compliant manufacturing facility.

Risks may arise from:

• Improper temperature
• Excess humidity
• Damaged packs
• Contamination
• Poor handling
• Falsified products
• Incorrect stock rotation
• Uncontrolled returns
• Theft
• Mix-ups
• Transport delays

WHO’s Good Storage and Distribution Practices guidance treats storage and distribution as important parts of medical-product supply-chain quality management.

Therefore, distributor selection should consider quality capability, not only sales turnover.

A Modern Pharma Distribution Channel         

A practical modern distribution system can be thought of as three connected flows.

Product Flow

Company → Warehouse → Distributor → Retailer → Patient

Information Flow

Market demand ← Sales data ← Distributor inventory ← Company ERP

Money Flow

Company ← Distributor payment ← Retailer payment ← Customer

A strong network manages all three.

Many companies concentrate only on product flow and then suffer from:

• Excess stock
• Outstanding payments
• Expiry
• Stock-outs
• Poor sales visibility

How to Develop a Strong Pharmaceutical Distribution Network

The correct sequence is:

1. Map the market and identify customers.
2. Estimate product-wise demand.
3. Divide the market into practical territories.
4. Decide which distribution levels are actually required.
5. Identify suitable licensed partners.
6. Conduct financial and operational due diligence.
7. Execute written agreements.
8. Set inventory and service-level standards.
9. Integrate ordering and stock reporting.
10. Monitor availability, expiry, returns, credit and delivery performance.
11. Expand only when existing territories are adequately serviced.
12. Periodically remove or restructure weak distribution points.

Step 1: Conduct a Market Survey

Distribution design should begin with data.

Do not appoint one distributor for an entire state merely because that distributor requests statewide rights.

Map the territory according to:

• Population
• Doctors
• Hospitals
• Retail pharmacies
• Nursing homes
• Prescription potential
• Existing competitors
• Transport connectivity
• Distance between markets
• Order frequency
• Product category

For institutional or specialty products, hospital concentration may be much more important than the total number of chemist shops.

Step 2: Classify Markets by Potential

Divide territories into categories such as:

Market	Characteristics	Distribution Strategy
High potential	High prescriptions/orders	Local distributor + frequent supply
Medium potential	Moderate orders	District/multi-district distributor
Developing	Low current demand	Supply through nearby distributor
Remote	Low density/high logistics cost	Consolidated scheduled dispatch

This is more economical than appointing one distributor in every district from the first day.

Step 3: Decide Coverage Radius

Ask:

How many customers can one distributor properly service?

The answer depends on:

• Product sales
• Geographic distance
• Retailer density
• Delivery frequency
• Salesperson coverage
• Transport infrastructure

A distributor supplying dense urban markets may serve hundreds of pharmacies efficiently.

A distributor covering widely separated rural markets may struggle with a much smaller customer base.

Therefore, territory should be based on serviceability, not only district boundaries.

Step 4: Decide How Many Inventory Points You Need

More stock points can improve product availability, but they also increase inventory.

Suppose you keep ₹5 lakh of safety stock at one central warehouse.

If you create ten regional stock points and each needs ₹2 lakh of minimum stock, total inventory may rise substantially.

That means more:

• Working capital
• Expiry exposure
• Slow-moving inventory
• Reconciliation

The objective is therefore not maximum stock points.

It is the minimum number of stock points required to achieve the promised service level.

Hub-and-Spoke Model

A useful structure for larger businesses is:

Central Warehouse

↓

Regional Hubs / C&F

↓

District Distributors

↓

Retailers

This works well when regional volumes are sufficient.

For smaller businesses:

Central Warehouse → Distributor → Retailer

may be more economical.

How to Select a Pharma Distributor

A distributor should be evaluated on several dimensions.

Area	What to Check
Licensing	Valid applicable drug licence
Market reach	Retailers/hospitals actually covered
Finance	Working-capital capacity
Storage	Suitable warehouse and refrigeration where needed
Manpower	Sales/delivery staff
Delivery	Vehicles/routes/frequency
Reputation	Payment and trade history
Technology	Billing/inventory software
Product fit	Existing therapeutic segments
Competition	Conflicting companies/products
Expiry handling	Stock rotation and returns
Reporting	Willingness to share inventory and sales data

Do not appoint a distributor solely because it offers to place a large opening order.

Opening Order Is Not Distribution Strength

An opening order of ₹10 lakh does not prove that a party has a good market network.

A strong distributor is one that can repeatedly:

receive → store → sell → collect → reorder

Products lying in the distributor’s warehouse are inventory, not sales.

Distributor Due Diligence

Before appointment, verify:

• Drug licences
• GST details
• Firm constitution
• Warehouse address
• Bank/payment history
• Existing agencies
• Market references
• Storage facilities
• Refrigerator/cold room where relevant
• Number of sales staff
• Number of delivery vehicles
• Retailer coverage
• Outstanding exposure
• Expiry experience

For higher-value territories, an actual site visit is preferable to completing the entire appointment through WhatsApp.

Distribution Agreement

A written agreement should define commercial and operational responsibilities.

Important provisions normally cover territory, products, purchase targets, payment terms, credit limit, stock norms, storage, delivery obligations, expiry/return policy, damages, recalls, confidentiality, trademark use, reporting, termination and settlement of closing stock.

A good agreement prevents later arguments such as:

“I thought I had exclusive rights for the whole state.”

Monopoly or Exclusive Distribution

PCD companies often provide monopoly rights.

Monopoly should not mean that the company permanently blocks an entire district regardless of performance.

An agreement can link exclusivity to:

• Minimum purchase
• Payment discipline
• Active market coverage
• Territory development
• Compliance
• Review period

A weak distributor holding a large exclusive territory can prevent the company from growing.

Inventory Management

A strong distribution system must maintain enough stock to avoid lost sales but not so much that products expire.

A practical inventory model uses:

Average demand + Replenishment lead time + Safety stock

Products should also be classified by movement.

Category	Example Approach
Fast moving	Higher safety stock
Medium moving	Moderate stock
Slow moving	Low stock
New products	Controlled launch quantity
Seasonal	Demand-based stock
Cold-chain/high value	Tight control

ABC Analysis

Products can be classified based on sales or inventory value.

A products contribute high value and need close monitoring.

B products are medium importance.

C products contribute relatively low value.

This helps management concentrate working capital where it matters most.

FSN Analysis

For pharmaceutical distribution, an additional useful method is:

F – Fast moving

S – Slow moving

N – Non-moving

Non-moving inventory should be identified early rather than six months before expiry.

FEFO Is More Important Than FIFO

For medicines, stock rotation should generally follow:

FEFO — First Expiry, First Out

rather than relying only on:

FIFO — First In, First Out

A newer batch with an earlier expiry should ordinarily be dispatched first.

Good storage/distribution principles place strong emphasis on maintaining product quality and appropriate inventory control throughout storage and distribution.

Define Minimum Remaining Shelf Life

Your distributor agreement should specify acceptable remaining shelf life at delivery.

For example, a distributor should not unexpectedly receive products with very little shelf life merely because the manufacturer wants to clear inventory.

WHO has separate guidance on determining appropriate remaining shelf life of medical products upon delivery.

The exact commercial limit should depend on:

• Product shelf life
• Sales velocity
• Supply route
• Customer requirement
• Tender conditions

Prevent Stock-Outs

A stock-out occurs when market demand exists but stock is unavailable.

Common causes include:

• Poor forecasting
• Delayed production
• Distributor not reordering
• Outstanding payment block
• Transport delay
• Demand spike
• Poor communication

A simple reorder system can use:

Reorder Point = Expected Demand During Lead Time + Safety Stock

Do not wait until inventory reaches zero.

Fill Rate

One of the best measures of distribution quality is order fill rate.

If a distributor orders 100 saleable line items and you supply 94 completely, the fill rate is approximately 94%.

A company with repeated stock-outs will eventually lose prescriptions and retailer confidence even if its marketing is excellent.

Order Cycle Time

Measure:

Order received → Order processed → Dispatched → Delivered

For example:

Order received: Monday 10 AM
Dispatch: Monday 5 PM
Delivery: Tuesday 4 PM

This is much more useful than simply saying:

“We dispatch quickly.”

On-Time In-Full Delivery

A stronger KPI is OTIF — On Time In Full.

It asks whether the customer received:

• Correct product
• Correct quantity
• Complete order
• Within promised delivery time

This is a practical measure of supply reliability.

Temperature-Controlled Products

Some medicines require controlled temperature during storage and distribution.

Where product labelling requires refrigerated or other temperature-controlled conditions, the distribution system should maintain those conditions during:

• Warehousing
• Picking
• Packing
• Dispatch
• Transportation
• Intermediate storage
• Delivery

WHO provides specific guidance for storage and transport of time- and temperature-sensitive pharmaceutical products.

A normal courier service should not be assumed to be suitable for every cold-chain medicine.

Temperature Excursions

Suppose a product requiring controlled refrigerated storage is exposed to an unacceptable temperature during transportation.

Do not simply cool it again and sell it.

The incident should be:

identified → quarantined → investigated → scientifically assessed → released or rejected by authorized quality personnel

depending on the company’s quality system.

Transportation Qualification

For sensitive products, assess:

• Route duration
• Seasonal temperature
• Vehicle type
• Packaging
• Cool packs
• Data loggers
• Transit delays
• Loading/unloading

WHO’s distribution guidance includes specific technical resources for temperature-controlled transport operations and transport monitoring.

Batch Traceability

A pharma distribution system should be able to answer:

Which distributor received Batch ABC123?

and ideally:

Which locations subsequently received that batch?

Maintain information such as:

Information	Purpose
Product	Identification
Batch number	Traceability
Expiry	Stock control
Quantity	Reconciliation
Customer	Recall traceability
Invoice	Commercial proof
Dispatch date	Distribution history

Traceability supports both recalls and detection of suspect supply-chain activity. WHO notes that medical-product traceability can strengthen supply-chain integrity and help earlier detection and response.

Product Recall System

Distribution networks must be able to reverse direction.

Normal distribution:

Company → Distributor → Retailer

Recall:

Retailer → Distributor → Company

A company should therefore maintain an updated distribution record for every batch.

A mock recall can be used periodically to test whether the company can quickly identify where affected stock has gone.

Returns and Expiry Management

Create a written policy for:

• Near-expiry stock
• Expired products
• Damaged products
• Market returns
• Recalled batches
• Transit breakage

Returned medicines should not automatically go back into saleable inventory.

Their status should be evaluated under defined procedures.

Digital Distribution Management

Modern distribution should not depend entirely on telephone calls and handwritten stock statements.

Useful systems include:

• ERP
• Distributor management software
• Inventory software
• E-invoicing systems where applicable
• Batch/expiry tracking
• Sales dashboards
• CRM
• Delivery tracking
• Automated reorder alerts

The purpose of technology is not to create more reports.

It should answer practical questions such as:

Which distributor will run out of Orthozac next week?

Which batch will expire in the next six months?

Which territory has increasing secondary sales?

Primary, Secondary and Tertiary Sales

These terms are extremely useful.

Primary Sales

Company sells to distributor.

Secondary Sales

Distributor sells to retailer/hospital.

Tertiary or Offtake

Retailer sells to final customer/patient.

A company that only measures primary sales may believe a territory is performing well even though stock is accumulating with the distributor.

Example

Company sells ₹10 lakh to distributor.

Distributor sells only ₹3 lakh to retailers.

Primary sale = ₹10 lakh.

Secondary sale = ₹3 lakh.

Unsold stock is approximately ₹7 lakh before considering opening inventory and other adjustments.

That territory may actually have a serious inventory problem.

Prescription/Ethical Pharma Distribution

In ethical prescription marketing, demand is influenced by prescribers, but the physical product generally flows through licensed distribution channels.

A practical structure may be:

Company → C&F/Stockist → Distributor → Retail Pharmacy → Patient

Marketing flow may separately be:

Company → Sales Team → Healthcare Professional

Doctors should therefore be treated as part of the demand-generation ecosystem, not as another warehouse level.

Interactions with healthcare professionals must also comply with the Uniform Code for Pharmaceutical Marketing Practices. The Department of Pharmaceuticals states that UCPMP applies to pharmaceutical companies, their employees, agents and third parties acting on their behalf in marketing medicines.

How to Build Distribution for Prescription Medicines

Begin with the prescribing universe.

Map:

Market Information	Why It Matters
Doctors by speciality	Potential prescription generation
Hospitals	Patient concentration
Nearby pharmacies	Prescription conversion
Existing stockists	Product availability
Distributor delivery routes	Service capability
Competitors	Market expectations

The highest-priority pharmacies are often those located near doctors and hospitals where prescriptions are generated.

But also cover neighbourhood pharmacies because patients may purchase medicines closer to home.

Generic Medicine Distribution

Generic marketing is usually much more trade-driven.

The major focus is:

Product availability + price + retailer economics + fast replenishment

A common structure may be:

Company → Super Stockist/Distributor → Retail Pharmacy → Consumer

Retailer coverage is often more important than doctor coverage.

Key measures should include:

• Number of active retail outlets
• Repeat orders
• Outlet-wise sales
• Distributor fill rate
• Expiry
• Credit
• Delivery frequency

PCD Pharma Franchise Distribution

PCD distribution works differently.

The company normally develops franchise partners, and each franchise partner develops its own local market.

A typical structure is:

Manufacturer/PCD Company → Franchise Partner → Distributor/Stockist where needed → Retail Pharmacy/Hospital → Patient

A smaller franchise partner may directly supply retailers and not need a separate stockist level.

The central PCD company should focus on:

• Fast dispatch
• Product availability
• Low stock-outs
• Transparent monopoly areas
• Reasonable MOQ
• Expiry policy
• Product launches
• Order tracking

For PCD, service quality from the company to the franchise partner is often as important as the local retail distribution itself.

PCD Monopoly Area Planning

Do not allocate territory merely according to postal district.

Analyse:

Expected potential ÷ Partner’s capacity to cover it

One PCD partner may manage an entire low-volume district.

A high-volume urban district may eventually require several territories.

The monopoly policy should provide a mechanism for reviewing area performance.

OTC Distribution

OTC-style consumer products depend more heavily on broad availability.

The distribution objective becomes:

Maximum relevant retail reach

Potential outlets may include, subject to the product’s legal sale conditions:

• Pharmacies
• Hospitals
• Relevant retail outlets
• Modern trade
• Other lawful channels

The exact channel depends on the product classification.

Do not call a prescription medicine “OTC” merely because it is commonly sold without a prescription.

Medical Device Distribution

Medical devices should not simply be placed under the pharmaceutical drug distribution model.

The Medical Devices Rules, 2017 provide a separate regulatory system. CDSCO lists G.S.R. 754(E), dated September 30, 2022, covering regulation of retail and wholesale sale of medical devices through registration of premises.

Device distributors should therefore be evaluated against the applicable medical-device requirements.

Distribution of Surgical and Medical Devices

The most suitable distributor depends on the device.

For hospital devices, evaluate:

• Number of target hospitals
• Relevant specialties
• Procedure volumes
• Procurement system
• Biomedical department
• Tender activity
• Technical-support needs

A conventional tablet distributor may not be suitable for a product requiring:

• Installation
• Demonstration
• Surgeon training
• Calibration
• Maintenance
• Technical support

Distributor specialization matters more than the number of shops covered.

Hospital and Institutional Distribution

Institutional distribution has different priorities.

Hospitals may require:

• Vendor registration
• Rate contracts
• Tender participation
• Credit
• Emergency supply
• Batch documents
• Certificates
• Dedicated logistics

The company may use:

Manufacturer → Institutional Distributor → Hospital

or direct supply where legally and commercially appropriate.

Direct Distribution vs Multi-Level Distribution

Direct/Short Channel	Multi-Level Channel
Better control	Better geographic reach
Higher delivery burden	Regional inventory available
Lower intermediary margin	More channel cost
Suitable for concentrated market	Suitable for large territory
More invoices/customers	Consolidated company billing
Less distributor inventory	More stock points

Neither model is automatically superior.

Use economics and service levels.

Last-Mile Delivery

The “last mile” is the final movement of goods to the retailer, hospital or other customer.

Problems often occur here because orders are small and delivery addresses are numerous.

Improve last-mile economics through:

• Fixed delivery routes
• Minimum order thresholds
• Scheduled market days
• Order cut-off times
• Route consolidation
• Local delivery staff
• Proof of delivery

For example:

Orders before 2 PM → Same-day dispatch

Orders after 2 PM → Next working day

A clear service promise is better than vague commitments.

Distributor Service-Level Agreement

A company can define measurable expectations.

KPI	Example Internal Target
Order fill rate	≥95%
OTIF	≥95%
Dispatch time	Within agreed hours
Expiry	Below defined threshold
Stock reporting	Weekly/monthly
Stock-out	Below agreed level
Outstanding	Within credit terms

The numbers above are examples for internal business planning, not legal requirements.

Credit Control Is Part of Distribution

An unlimited-credit network is not a strong distribution network.

Before giving credit, define:

• Credit limit
• Credit days
• Security
• Outstanding monitoring
• Payment behaviour
• Stop-supply rules

Sales that are never collected are not profitable distribution.

Distributor Profitability Matters

A distributor will prioritize companies that provide sufficient return on:

• Investment
• Warehouse space
• Working capital
• Delivery expense
• Sales effort

If your products have:

• Low movement
• Poor margins
• Long credit
• High expiry

the distributor may technically remain appointed but stop promoting or stocking them.

Channel partners must have an economically sustainable model.

Communication System

The company and distributor should exchange regular information about:

Distributor → Company

Sales, stock, expiry, retailer feedback, competition, payment.

Company → Distributor

Supply status, price changes, schemes, product launch, batch availability, policy changes, recalls.

Many distribution failures are actually communication failures.

How Often Should You Supply?

Supply frequency should be based on demand.

Fast-moving territories may need:

• Daily
• Alternate-day
• Twice-weekly

replenishment at local levels.

Low-volume territories may work with weekly or consolidated delivery.

A lower delivery frequency can be economical but requires higher safety stock.

How to Measure Distribution Strength

Do not measure your network only by:

“We have 500 distributors.”

A better scorecard is:

KPI	What It Shows
Active distributors	Genuine network size
Active retailers	Market reach
Secondary sales	Actual movement
Repeat-order rate	Product acceptance
Stock availability	Service
Fill rate	Supply performance
OTIF	Delivery performance
Inventory days	Working-capital efficiency
Expiry %	Inventory quality
Collection days	Financial health
Returns	Product/channel problems

One hundred active distributors can be more valuable than 1,000 appointed-but-inactive parties.

Numerical Distribution

Numerical distribution measures how many relevant outlets stock your product.

Suppose:

Target pharmacies = 1,000
Pharmacies stocking product = 600

Numerical Distribution = 600 ÷ 1,000 × 100 = 60%

This helps measure market availability.

Weighted Distribution

All retailers do not contribute equally.

If your product is available in large high-volume pharmacies but absent from many very small shops, weighted distribution may be much stronger than numerical distribution suggests.

Therefore, prioritize important outlets rather than chasing outlet count alone.

How to Find New Distributors

Potential distributors can be identified through:

• Existing retailer references
• Stockist associations
• Sales teams
• Hospitals
• Trade exhibitions
• Industry directories
• B2B enquiries
• Existing franchise network
• Referrals from neighbouring distributors
• Local market visits

Market references are particularly useful because retailers know which distributors actually deliver on time.

Warning Signs of a Weak Distributor

Warning signs include repeated payment delays, refusal to share stock information, high expiry, no delivery staff, excessive competing agencies, poor retailer reputation, frequent disputes, unexplained inventory differences and constant requests for additional credit without corresponding secondary sales.

The company should intervene early rather than waiting until the territory collapses.

When to Appoint an Additional Distributor

Consider another distributor when:

• Existing partner cannot cover the territory
• Delivery times are poor
• Sales opportunity is being lost
• Retailers complain of supply gaps
• Existing distributor lacks working capital
• Territory has grown beyond its capacity

However, before breaking exclusivity, follow the written agreement and provide a documented performance review.

When to Remove a Distributor

Termination may be justified by issues such as:

• Licence problems
• Persistent non-payment
• Falsification
• Poor storage
• Repeated stock-outs
• Territory neglect
• Diversion
• Serious contractual breach

Ensure closing stock, claims, outstanding payments and brand materials are properly reconciled.

Distribution Network During Product Recall

Your system should be capable of answering quickly:

Which batch?

How much was produced?

Who received it?

How much remains?

How much has been recovered?

This is why batch-wise distributor and invoice records matter.

WHO emphasizes the responsibility of licensed and regulated distributors, wholesalers and retailers to follow good storage and distribution practices and to be able to show where medical products were sourced.

Common Mistakes in Pharma Distribution

Common mistakes are appointing too many distributors before demand exists, granting huge monopoly areas without sales conditions, measuring only primary sales, giving excessive credit, ignoring expiry, poor cold-chain management, appointing unlicensed parties, keeping no batch traceability, depending on one C&F for a large region without contingency, selecting distributors only on opening order size, and failing to review secondary sales.

A Better Distribution Strategy for a New Pharma Company

For a new company, begin with a small number of territories where you can provide excellent service.

Establish:

good availability → repeat prescriptions/orders → stable secondary sales → reliable collections

Then expand.

Expanding into 20 states while struggling to supply products in five states usually damages both working capital and reputation.

Distribution Expansion Example

A sensible expansion could look like:

Phase 1: One state with direct distributors.

Phase 2: Neighbouring states with regional distributors.

Phase 3: Regional C&F or super-stockist if volume justifies it.

Phase 4: National warehouse network based on sales density.

The distribution structure should evolve with sales.

Final Answer

A pharmaceutical distribution channel is the network through which medicines move from the manufacturer or marketing company to the final customer.

A typical channel may be:

Manufacturer → C&F → Stockist → Distributor → Retailer → Patient

but that is only one model.

The correct channel may instead be:

Manufacturer → Distributor → Retailer → Patient

or, in PCD marketing:

PCD Company → Franchise Partner → Retailer/Hospital → Patient

The objective should not be to create the largest possible network.

The objective should be to create a network that provides:

availability + compliance + quality + speed + traceability + economical inventory + timely payment.

The most successful distribution systems measure not only how much stock the company sells to distributors, but also:

secondary sales, stock availability, expiry, order fill rate, delivery time, retailer coverage and collections.

A distributor is useful only when products continue moving through the channel and remain available where actual demand exists.

Frequently Asked Questions

What is a pharma distribution channel?

It is the network through which pharmaceutical products move from the manufacturer or marketing company to wholesalers, distributors, pharmacies, hospitals and ultimately the patient.

Is a doctor part of the distribution channel?

Normally no. Doctors may influence demand through lawful prescribing, but they do not normally form part of the physical movement and sale channel.

Is C&F compulsory?

No. It is commercially useful when regional volumes justify an intermediate warehousing and dispatch point.

What is the difference between distributor and stockist?

The terms vary in practice. Some companies use “stockist” for larger inventory holders and “distributor” for parties covering retailers. The agreement should define the actual role.

What licences should a pharma distributor have?

The party should hold the drug-sale licences applicable to the products and activities involved. CDSCO’s 2026 amendments also updated conditions relating to wholesale licence forms and competent persons.

What is FEFO?

FEFO means First Expiry, First Out. Products with the earliest expiry should generally move first.

What is primary sale?

Primary sale is the company’s sale to its distributor or stockist.

What is secondary sale?

Secondary sale is the distributor’s sale to retailers or hospitals.

Which is more important: primary or secondary sales?

Both matter, but secondary sales are essential for understanding whether products are actually moving into the market rather than accumulating at distributors.

How many distributors should one company appoint?

There is no fixed number. It depends on market demand, geography, order density, delivery capability and sales volume.

Should one distributor cover one district?

Not necessarily. A high-volume district may need multiple coverage points, while one distributor may efficiently cover several low-volume districts.

How can expiry be reduced?

Use better forecasting, FEFO, lower stock of slow-moving products, regular expiry reports, stock transfers where permitted, and faster action on non-moving inventory.

What is a strong distribution KPI?

Useful KPIs include order fill rate, OTIF, secondary sales, stock-out rate, inventory days, expiry percentage, active outlets and collection days.

Are medical-device distributors regulated like ordinary pharma distributors?

Medical devices have a separate regulatory framework. CDSCO’s Medical Devices Rules page includes the 2022 notification covering retail and wholesale sale of medical devices through registration of premises.

What is the most important principle of pharma distribution?

The product should be available when needed while remaining within approved storage, quality, legal and traceability requirements throughout the supply chain.

---

Looking for Ayurvedic Franchise or Distribution Opportunities?

Looking to start an Ayurvedic franchise, become a distributor, or launch your own herbal product range?

Elzac Herbal India offers:

• Ayurvedic & Herbal Product Range
• Franchise & Distribution Opportunities
• Third-Party Manufacturing
• Product Development Support
• Marketing Guidance
• PAN India Business Opportunities

Whether you are an entrepreneur, retailer, distributor, or healthcare professional, our team can help you explore the right business opportunity in the growing Ayurvedic sector.

Contact us today to discuss ayurvedic franchise, distribution, or third-party manufacturing opportunities.